Fosun Pharma looks to digest India's Gland, eyes other markets

SHANGHAI, Sept 13 (Reuters) - Chinese drugmaker Shanghai

Fosun Pharmaceutical Group Co Ltd already has one

eye on investments in other overseas markets after it announced

a nearly $1.3 billion deal in July to India's Gland Pharma, the

firm's chairman said on Tuesday.

Read more